BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Clinical trial NCT03355976 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03355976
Sponsor: Brown University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma Extra Renal Origin Clear Cell Adenocarcinoma

Start date: 2018-04-30
Primary completion: 2026-10-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.